Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor

BACKGROUND AND OBJECTIVES: Obesity is a global epidemic which increases the risk of the metabolic syndrome. Cathelicidin (LL-37 and mCRAMP) is an antimicrobial peptide with an unknown role in obesity. We hypothesize that cathelicidin expression correlates with obesity and modulates fat mass and hepa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Obes (Lond)
Autori principali: Tran, Deanna Hoang-Yen, Tran, Diana Hoang-Ngoc, Mattai, S. Anjani, Sallam, Tamer, Ortiz, Christina, Lee, Elaine C., Robbins, Lori, Ho, Samantha, Lee, Jung Eun, Fisseha, Elizabeth, Shieh, Christine, Sideri, Aristea, Shih, David Q, Fleshner, Philip, McGovern, Dermot PB, Vu, Michelle, Hing, Tressia C., Bakirtzi, Kyriaki, Cheng, Michelle, Su, Bowei, Law, Ivy, Karagiannides, Iordanes, Targan, Stephan R., Gallo, Richard L., Li, Zhaoping, Koon, Hon Wai
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014693/
https://ncbi.nlm.nih.gov/pubmed/27163748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2016.90
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi